October 14, 2025

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook Reveals 168.74% Upside Potential

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical powerhouse in the biotechnology industry, is capturing investor attention with its promising pipeline focused on rare and ultra-rare genetic diseases. With a market..

Disc Medicine, Inc. (IRON) Stock Analysis: Analyst Ratings Shine with a 38.59% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON) has captured the attention of investors with its promising pipeline in the biopharmaceutical landscape. As a clinical-stage biotech company, it stands out with a focus..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Unveiling a 20.66% Upside Potential for Investors

For investors looking to diversify their portfolios with a robust healthcare play, U.S. Physical Therapy, Inc. (NYSE: USPH) offers a compelling opportunity. Headquartered in Houston, Texas, USPH operates and manages..

Supernus Pharmaceuticals (SUPN): Investor Outlook on a Promising 12% Upside Potential

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) stands as a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $2.71 billion,..

Tandem Diabetes Care, Inc. (TNDM)

⚠️ No article content returned.

..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a Potential 113.70% Upside for Savvy Investors

Innoviva, Inc. (NASDAQ: INVA), a biopharmaceutical company based in Burlingame, California, is drawing the attention of investors with an impressive potential upside of 113.70%. With a current stock price of..

Galapagos NV (GLPG) Stock Analysis: Navigating Challenges with a -25.46% Potential Downside

Galapagos NV (GLPG), a Belgium-based biotechnology company, has crafted a unique niche by focusing on innovative therapies for oncology and immunology. However, the latest financial data presents a complex picture..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Navigating Growth Potential in the Biotechnology Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a prominent player in the biotechnology sector, is making waves with its innovative approach to harnessing the power of the immune system for diagnostic and..

Neogen Corporation (NEOG) Stock Analysis: Prospects Amidst a 28.85% Potential Upside in the Diagnostics & Research Sector

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing opportunity for investors amidst current market dynamics. With a..

Acadia Healthcare (ACHC) Stock Analysis: Exploring a 22.33% Upside Potential in the Healthcare Sector

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is an intriguing prospect for investors seeking exposure to the healthcare sector, particularly within medical care facilities specializing in behavioral health. As a prominent..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 37% Potential Upside for Investors

Schrodinger, Inc. (SDGR), a leading player in the healthcare sector, specifically within the health information services industry, is capturing investor attention with a potential upside of 37.06%. Based in New..

Artivion, Inc. (AORT) Stock Analysis: Healthcare Innovator with 11.39% Potential Upside

Artivion, Inc. (NASDAQ: AORT), a prominent player in the healthcare sector, specializes in manufacturing, processing, and distributing medical devices and implantable human tissues globally. With a market capitalization of $1.92..

QuidelOrtho Corporation (QDEL) Stock Analysis: A Healthcare Play with Nearly 49% Upside Potential

QuidelOrtho Corporation (NASDAQ: QDEL) stands as a notable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $1.79 billion, the company is headquartered..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a 110.95% Potential Upside in the Biotechnology Sector

Denali Therapeutics Inc. (DNLI) has emerged as a compelling player in the biotechnology sector, focusing on developing innovative therapeutics for neurodegenerative and lysosomal storage diseases. With a market capitalization of..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 55% Upside Potential

Surgery Partners, Inc. (NASDAQ: SGRY) has caught the attention of individual investors with its significant upside potential, as highlighted by an impressive 55.73% increase based on the current average target..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 52.96% Potential Upside

Investors with an eye on the healthcare sector might find ICU Medical, Inc. (NASDAQ: ICUI) an intriguing opportunity, particularly with its substantial potential upside of 52.96%. Headquartered in San Clemente,..

Liquidia Corporation (LQDA) Stock Analysis: Unveiling a 55% Potential Upside in the Biotech Sector

Liquidia Corporation (NASDAQ: LQDA) stands at an intriguing juncture in the biotechnology sector, boasting a market capitalization of $2.05 billion. Investors are increasingly eyeing this U.S.-based biopharmaceutical company, driven by..

Astrana Health Inc. (ASTH) Stock Analysis: Navigating a 53% Potential Upside with Strong Revenue Growth

Astrana Health Inc. (NASDAQ: ASTH), a rising star in the healthcare management sector, is catching the eye of investors with its compelling growth metrics and substantial potential upside. Headquartered in..

Novavax, Inc. (NVAX) Stock Analysis: Potential Upside Amidst Challenges in the Biotech Sector

Novavax, Inc. (NVAX), a prominent player in the biotechnology sector, is making waves with its innovative approach to vaccine development. Headquartered in Gaithersburg, Maryland, Novavax engages in discovering, developing, and..

PACS Group, Inc. (PACS) Stock Analysis: Unpacking the 179.57% Potential Upside

PACS Group, Inc. (PACS), a player in the healthcare sector specializing in medical care facilities, has caught the attention of investors with its significant potential upside. Based in Farmington, Utah,..

Search

Funds

October 14, 2025

Search

Funds

October 14, 2025

FTSE 100

Funds